European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

European Medicine Agency (EMA)

The European Medicine Agency (EMA) has established ‘eligibility criteria’ in order to make sure that it only establishes dialogues with the most suitable organisations that act in the interests of European patients, consumers and healthcare professionals. The European Association of Urology would like to engage in dialogue with the EMA and has provided the following information for the evaluation of eligibility.

Annual Financial Assessment

As part of the evaluation for eligibility, the European Association of Urology has provided the following financial information (2023) to be assessed by the parameters as set by the European Medicine Agency:

Income from industry:

  • Registration fees - 36.65%
  • Publications - 9.51%
  • Membership fees - 10.41%
  • Other income - 0.05%

The overall proportion of industry and non-industry:

43.43% vs 56.57% 

Funding Resources

The following pharmaceutical companies provide funding to EAU:

  • Astellas Pharma Europe Ltd
  • Pfizer Inc.
  • Merck Sharp & Dohme LLC
  • Pierre Fabre Medicament
  • Janssen Pharmaceutical N.V.
  • Advanced Accelerator Applications International S.
  • AstraZeneca UK Ltd.
  • Medscape LLC.
  • IBSA Institut Biochemique SA
  • Recordati Industria Chimica e farmaceutica S.p.A.

The following medtech companies provide funding to EAU:

  • Intuitive Surgical Sarl
  • Olympus Europa SE & CO. KG
  • Medtronic International Trading Sàrl
  • Karl Storz SE & Co. KG
  • Procept Biorobotics
  • Covidien AG
  • Cook Medical Europe Ltd.
  • Quanta System SPA
  • Boston Scientific International S.A.
  • Richard Wolf GmbH

The highest contribution from a single company is less than 3.64% of the organisation’s total income. The financial Annual Report of 2023 by EAU can be found here: Compilation Report.

Geographic Spread of EAU Membership
Enlarge image

Code of Ethics

In order to ensure good governance, interactions should be based on fundamental principles of integrity, mutual respect, responsiveness, accountability, collaboration and transparency. The EAU Code of Ethics set standards for industry partners with regard to ethical interactions with the healthcare community. In order to make funding partnerships work in practice, to ensure the integrity of both the funder and EAU is maintained, and to demonstrate to other stakeholders that our relationships are absolutely scrupulous, the following key principles underpin our acceptance of funding.

EAU Code of Ethics
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer